Filing Details

Accession Number:
0001415889-24-019341
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-08 16:30:09
Reporting Period:
2024-02-19
Accepted Time:
2024-07-08 16:30:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1231457 Genelux Corp GNLX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1983187 Caroline Jewett C/O Genelux Corporation
2625 Townsgate Road, Suite 230
Westlake Village CA 91361
Head Of Quality No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-19 1,143 $0.00 22,278 No 4 A Direct
Common Stock Acquisiton 2024-03-14 3,612 $0.00 25,890 No 4 A Direct
Common Stock Disposition 2024-06-24 4,961 $2.12 16,174 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of February 17, 2024.
  2. Represents RSUs that are fully vested as of March 14, 2024.
  3. Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of the RSUs.